BCA
ORGO icon

Berman Capital Advisors’s Organogenesis Holdings ORGO Stock Holding History

Berman Capital Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$2K Buy
+201
New +$3.12K ﹤0.01% 1720

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Berman Capital Advisors's ORGO Position: Q3 2021 in Review

Berman Capital Advisors opened a new position in Organogenesis Holdings (ORGO) in Q3 2021: 201 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1720 among its holdings.

153 funds tracked by Wall St. Rank hold ORGO as of Q3 2021.

  • Berman Capital Advisors held 201 shares of Organogenesis Holdings worth $2K as of Q3 2021.
  • Organogenesis Holdings was a new Berman Capital Advisors position in Q3 2021.
  • Organogenesis Holdings made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1720 holding.
  • 153 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.